Profil
Chad Morin is currently Chief Compliance Officer & Vice President at Kiniksa Pharmaceuticals Ltd. since 2020.
Former positions include Head-Compliance at ARIAD Pharmaceuticals, Inc., Chief Compliance Officer & Senior Vice President at Kiniksa Pharmaceuticals International Plc from 2020 to 2025, and Chief Compliance Officer & Vice President at Genetix Biotherapeutics, Inc. Education includes undergraduate studies at F.W.
Olin Graduate School of Business.
Postes actifs de Chad Morin
| Sociétés | Poste | Début |
|---|---|---|
Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and delivers therapeutic medicines for patients suffering from cardiovascular diseases | Compliance Officer | 01/10/2020 |
Anciens postes connus de Chad Morin
| Sociétés | Poste | Fin |
|---|---|---|
| ARIAD PHARMACEUTICALS, INC. | Compliance Officer | - |
| GENETIX BIOTHERAPEUTICS, INC. | Compliance Officer | - |
Formation de Chad Morin
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
ARIAD Pharmaceuticals, Inc.
ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes small-molecule drugs for the treatment of cancer | Health Technology |
bluebird bio, Inc.
bluebird bio, Inc. BiotechnologyHealth Technology Develops genetic therapies based on blood stem cells | Health Technology |
F.W. Olin Graduate School of Business
F.W. Olin Graduate School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and delivers therapeutic medicines for patients suffering from cardiovascular diseases | Health Technology |
















